nodes	percent_of_prediction	percent_of_DWPC	metapath
Bevantolol—Carvedilol—SELE—atherosclerosis	0.0592	0.439	CrCbGaD
Bevantolol—Carvedilol—VCAM1—atherosclerosis	0.0565	0.419	CrCbGaD
Bevantolol—Carvedilol—VEGFA—atherosclerosis	0.0191	0.141	CrCbGaD
Bevantolol—ADRB1—GPCR downstream signaling—KNG1—atherosclerosis	0.000892	0.00103	CbGpPWpGaD
Bevantolol—ADRB2—GPCR ligand binding—CCL2—atherosclerosis	0.000889	0.00103	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—AGTR1—atherosclerosis	0.000886	0.00102	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CCL4—atherosclerosis	0.000886	0.00102	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—KNG1—atherosclerosis	0.000872	0.00101	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—AGTR1—atherosclerosis	0.000867	0.001	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—CCL3—atherosclerosis	0.000847	0.000979	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—APOA2—atherosclerosis	0.000846	0.000978	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—CCR2—atherosclerosis	0.000844	0.000975	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—EDNRA—atherosclerosis	0.000844	0.000975	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—APOA2—atherosclerosis	0.000827	0.000956	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR ligand binding—F2—atherosclerosis	0.000825	0.000954	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—GHRL—atherosclerosis	0.000822	0.00095	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—KNG1—atherosclerosis	0.00081	0.000936	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—UTS2—atherosclerosis	0.000807	0.000933	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—AGTR1—atherosclerosis	0.000805	0.00093	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—APOA4—atherosclerosis	0.000795	0.000919	CbGpPWpGaD
Bevantolol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—atherosclerosis	0.000792	0.000916	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—KNG1—atherosclerosis	0.000792	0.000916	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—UTS2—atherosclerosis	0.000789	0.000912	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—AGTR1—atherosclerosis	0.000787	0.00091	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CX3CR1—atherosclerosis	0.000774	0.000894	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CASR—atherosclerosis	0.000774	0.000894	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—EDNRA—atherosclerosis	0.000766	0.000885	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—CCR2—atherosclerosis	0.000766	0.000885	CbGpPWpGaD
Bevantolol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000764	0.000883	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CX3CL1—atherosclerosis	0.000759	0.000877	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CX3CR1—atherosclerosis	0.000757	0.000875	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CASR—atherosclerosis	0.000757	0.000875	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—EDN1—atherosclerosis	0.000752	0.000869	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—GHRL—atherosclerosis	0.000747	0.000863	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—CCL5—atherosclerosis	0.000746	0.000862	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CX3CL1—atherosclerosis	0.000742	0.000858	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR ligand binding—CCL2—atherosclerosis	0.000736	0.00085	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—EDN1—atherosclerosis	0.000735	0.00085	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CCL4—atherosclerosis	0.000732	0.000847	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—CCL5—atherosclerosis	0.000729	0.000843	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—KNG1—atherosclerosis	0.000722	0.000834	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CNR2—atherosclerosis	0.000719	0.000831	CbGpPWpGaD
Bevantolol—ADRB1—GPCR ligand binding—CXCL8—atherosclerosis	0.000719	0.000831	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—MMP3—atherosclerosis	0.000718	0.000829	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—AGTR1—atherosclerosis	0.000717	0.000829	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—PRKCG—atherosclerosis	0.000709	0.000819	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CNR2—atherosclerosis	0.000704	0.000813	CbGpPWpGaD
Bevantolol—ADRB2—GPCR ligand binding—CXCL8—atherosclerosis	0.000703	0.000813	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—MMP3—atherosclerosis	0.000702	0.000811	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—PRKCG—atherosclerosis	0.000694	0.000802	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—APOA2—atherosclerosis	0.000684	0.000791	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—EDN1—atherosclerosis	0.000682	0.000789	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—CCL5—atherosclerosis	0.000677	0.000783	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—EDN1—atherosclerosis	0.000668	0.000772	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—CCL5—atherosclerosis	0.000662	0.000766	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—KNG1—atherosclerosis	0.000655	0.000757	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—UTS2—atherosclerosis	0.000653	0.000755	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—AGTR1—atherosclerosis	0.000651	0.000753	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—PRKCG—atherosclerosis	0.000644	0.000744	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—VWF—atherosclerosis	0.000641	0.000741	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—APOC3—atherosclerosis	0.000637	0.000736	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—LDLR—atherosclerosis	0.000633	0.000732	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—PRKCG—atherosclerosis	0.00063	0.000728	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—VWF—atherosclerosis	0.000627	0.000725	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CASR—atherosclerosis	0.000626	0.000723	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CX3CR1—atherosclerosis	0.000626	0.000723	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—AGT—atherosclerosis	0.000624	0.000721	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—APOC3—atherosclerosis	0.000623	0.00072	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—LDLR—atherosclerosis	0.000619	0.000716	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CCL3—atherosclerosis	0.000618	0.000715	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CX3CL1—atherosclerosis	0.000614	0.000709	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—AGT—atherosclerosis	0.00061	0.000705	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—EDN1—atherosclerosis	0.000608	0.000703	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CCL3—atherosclerosis	0.000605	0.000699	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—CCL5—atherosclerosis	0.000603	0.000697	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—NCF1—atherosclerosis	0.000592	0.000684	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CNR2—atherosclerosis	0.000582	0.000673	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR ligand binding—CXCL8—atherosclerosis	0.000582	0.000672	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—MMP3—atherosclerosis	0.000581	0.000671	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—NCF1—atherosclerosis	0.000579	0.00067	CbGpPWpGaD
Bevantolol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	0.000579	0.00067	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—F2—atherosclerosis	0.000576	0.000666	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—PRKCG—atherosclerosis	0.000574	0.000663	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—AGT—atherosclerosis	0.000566	0.000655	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—F2—atherosclerosis	0.000564	0.000652	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CCR2—atherosclerosis	0.000559	0.000646	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—EDNRA—atherosclerosis	0.000559	0.000646	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CYBA—atherosclerosis	0.000557	0.000644	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—AGT—atherosclerosis	0.000554	0.00064	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—EDN1—atherosclerosis	0.000552	0.000638	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000552	0.000638	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—CCL5—atherosclerosis	0.000548	0.000633	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—EDNRA—atherosclerosis	0.000547	0.000632	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CCR2—atherosclerosis	0.000547	0.000632	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—PLAT—atherosclerosis	0.000545	0.00063	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—PARP1—atherosclerosis	0.000545	0.00063	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—GHRL—atherosclerosis	0.000545	0.00063	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CYBA—atherosclerosis	0.000545	0.00063	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—PIK3CG—atherosclerosis	0.00054	0.000624	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—GHRL—atherosclerosis	0.000533	0.000616	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—PLAT—atherosclerosis	0.000533	0.000616	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—PARP1—atherosclerosis	0.000533	0.000616	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—F2—atherosclerosis	0.000523	0.000605	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—PRKCG—atherosclerosis	0.000521	0.000602	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—VWF—atherosclerosis	0.000519	0.000599	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—APOC3—atherosclerosis	0.000515	0.000596	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—LDLR—atherosclerosis	0.000512	0.000592	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—F2—atherosclerosis	0.000512	0.000592	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—AGT—atherosclerosis	0.000505	0.000583	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—PIK3CG—atherosclerosis	0.000501	0.000579	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CCL3—atherosclerosis	0.0005	0.000578	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—PIK3CG—atherosclerosis	0.00049	0.000566	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—NCF1—atherosclerosis	0.000479	0.000554	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—KNG1—atherosclerosis	0.000478	0.000553	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—AGTR1—atherosclerosis	0.000476	0.00055	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—KNG1—atherosclerosis	0.000468	0.000541	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—CCL2—atherosclerosis	0.000467	0.000539	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—F2—atherosclerosis	0.000466	0.000539	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—AGTR1—atherosclerosis	0.000465	0.000538	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—PLG—atherosclerosis	0.000463	0.000536	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—AGT—atherosclerosis	0.000458	0.00053	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—CCL2—atherosclerosis	0.000456	0.000527	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—PLG—atherosclerosis	0.000453	0.000524	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—EDNRA—atherosclerosis	0.000453	0.000523	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CCR2—atherosclerosis	0.000453	0.000523	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CYBA—atherosclerosis	0.000451	0.000521	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000446	0.000516	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PARP1—atherosclerosis	0.000441	0.00051	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—GHRL—atherosclerosis	0.000441	0.00051	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PLAT—atherosclerosis	0.000441	0.00051	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—SOCS3—atherosclerosis	0.000439	0.000507	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—SOCS3—atherosclerosis	0.000429	0.000496	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—MMP3—atherosclerosis	0.000424	0.00049	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—F2—atherosclerosis	0.000424	0.000489	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—IGF2—atherosclerosis	0.000422	0.000488	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—MMP3—atherosclerosis	0.000415	0.000479	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—IGF2—atherosclerosis	0.000413	0.000477	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—APOB—atherosclerosis	0.00041	0.000473	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—CXCL8—atherosclerosis	0.000406	0.000469	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—PIK3CG—atherosclerosis	0.000405	0.000468	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—EDN1—atherosclerosis	0.000403	0.000466	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—APOB—atherosclerosis	0.000401	0.000463	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CCL5—atherosclerosis	0.0004	0.000462	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—CXCL8—atherosclerosis	0.000397	0.000459	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—EDN1—atherosclerosis	0.000394	0.000456	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CCL5—atherosclerosis	0.000391	0.000452	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—LPL—atherosclerosis	0.000391	0.000452	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—KNG1—atherosclerosis	0.000387	0.000447	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—AGTR1—atherosclerosis	0.000385	0.000445	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—LPL—atherosclerosis	0.000383	0.000442	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—PRKCG—atherosclerosis	0.00038	0.00044	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—CCL2—atherosclerosis	0.000377	0.000436	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PLG—atherosclerosis	0.000375	0.000433	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—PRKCG—atherosclerosis	0.000372	0.00043	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—SPP1—atherosclerosis	0.00037	0.000428	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—CXCL8—atherosclerosis	0.000369	0.000426	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—SPP1—atherosclerosis	0.000362	0.000419	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—CXCL8—atherosclerosis	0.000361	0.000417	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—SOCS3—atherosclerosis	0.000355	0.00041	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—MMP3—atherosclerosis	0.000343	0.000396	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—PDGFB—atherosclerosis	0.000343	0.000396	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—IGF2—atherosclerosis	0.000341	0.000395	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—PDGFB—atherosclerosis	0.000335	0.000388	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—AGT—atherosclerosis	0.000335	0.000387	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—APOB—atherosclerosis	0.000331	0.000383	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—CXCL8—atherosclerosis	0.000329	0.00038	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—LEP—atherosclerosis	0.000328	0.000379	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—APOE—atherosclerosis	0.000328	0.000379	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—AGT—atherosclerosis	0.000327	0.000378	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—EDN1—atherosclerosis	0.000326	0.000377	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CAV1—atherosclerosis	0.000325	0.000375	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—APOA1—atherosclerosis	0.000324	0.000375	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CCL5—atherosclerosis	0.000324	0.000374	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—APOE—atherosclerosis	0.000321	0.000371	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—LEP—atherosclerosis	0.000321	0.000371	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CAV1—atherosclerosis	0.000318	0.000367	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—APOA1—atherosclerosis	0.000317	0.000366	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—LPL—atherosclerosis	0.000316	0.000366	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—ESR1—atherosclerosis	0.000313	0.000362	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—F2—atherosclerosis	0.000309	0.000357	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PRKCG—atherosclerosis	0.000308	0.000356	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—ESR1—atherosclerosis	0.000306	0.000354	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—F2—atherosclerosis	0.000302	0.00035	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—SPP1—atherosclerosis	0.0003	0.000346	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—CXCL8—atherosclerosis	0.000298	0.000345	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—PIK3CG—atherosclerosis	0.000296	0.000342	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—PIK3CG—atherosclerosis	0.000289	0.000335	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—MAPK3—atherosclerosis	0.000283	0.000328	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—INS—atherosclerosis	0.00028	0.000324	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PDGFB—atherosclerosis	0.000277	0.000321	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—MAPK3—atherosclerosis	0.000277	0.00032	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CCL2—atherosclerosis	0.000276	0.000319	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—INS—atherosclerosis	0.000274	0.000317	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—IGF1—atherosclerosis	0.000271	0.000313	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—AGT—atherosclerosis	0.000271	0.000313	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CCL2—atherosclerosis	0.00027	0.000312	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—LEP—atherosclerosis	0.000265	0.000307	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—APOE—atherosclerosis	0.000265	0.000307	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—IGF1—atherosclerosis	0.000265	0.000306	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CAV1—atherosclerosis	0.000263	0.000304	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—APOA1—atherosclerosis	0.000262	0.000303	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—SERPINE1—atherosclerosis	0.000257	0.000297	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—ESR1—atherosclerosis	0.000253	0.000293	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—SERPINE1—atherosclerosis	0.000252	0.000291	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—F2—atherosclerosis	0.00025	0.000289	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—NOS3—atherosclerosis	0.000246	0.000284	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—NOS3—atherosclerosis	0.00024	0.000278	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PIK3CG—atherosclerosis	0.000239	0.000277	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—MAPK3—atherosclerosis	0.000229	0.000265	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—INS—atherosclerosis	0.000227	0.000262	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CCL2—atherosclerosis	0.000223	0.000258	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—IGF1—atherosclerosis	0.000219	0.000253	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CXCL8—atherosclerosis	0.000218	0.000252	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CXCL8—atherosclerosis	0.000213	0.000246	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—AKT1—atherosclerosis	0.00021	0.000243	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—SERPINE1—atherosclerosis	0.000208	0.000241	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—IL6—atherosclerosis	0.000207	0.000239	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—AKT1—atherosclerosis	0.000206	0.000238	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—IL6—atherosclerosis	0.000203	0.000234	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—NOS3—atherosclerosis	0.000199	0.00023	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—MMP9—atherosclerosis	0.000197	0.000228	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—NFKB1—atherosclerosis	0.000195	0.000225	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—MMP9—atherosclerosis	0.000193	0.000223	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—MAPK8—atherosclerosis	0.000192	0.000222	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—AKT1—atherosclerosis	0.000191	0.000221	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—NFKB1—atherosclerosis	0.000191	0.00022	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—MAPK8—atherosclerosis	0.000187	0.000217	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—AKT1—atherosclerosis	0.000187	0.000216	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—VEGFA—atherosclerosis	0.000177	0.000205	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CXCL8—atherosclerosis	0.000176	0.000204	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—STAT3—atherosclerosis	0.000175	0.000203	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—VEGFA—atherosclerosis	0.000173	0.0002	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—STAT3—atherosclerosis	0.000171	0.000198	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—AKT1—atherosclerosis	0.00017	0.000197	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—IL6—atherosclerosis	0.000168	0.000194	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—MAPK3—atherosclerosis	0.000167	0.000193	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—MAPK3—atherosclerosis	0.000164	0.000189	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—TGFB1—atherosclerosis	0.000162	0.000188	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—MMP9—atherosclerosis	0.000159	0.000184	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—TGFB1—atherosclerosis	0.000159	0.000184	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—NFKB1—atherosclerosis	0.000158	0.000182	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—MAPK8—atherosclerosis	0.000155	0.000179	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—AKT1—atherosclerosis	0.000155	0.000179	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—VEGFA—atherosclerosis	0.000143	0.000165	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—STAT3—atherosclerosis	0.000142	0.000164	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—MAPK3—atherosclerosis	0.000135	0.000157	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—TGFB1—atherosclerosis	0.000131	0.000152	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—IL6—atherosclerosis	0.000122	0.000141	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—IL6—atherosclerosis	0.00012	0.000138	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—AKT1—atherosclerosis	0.000113	0.000131	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—AKT1—atherosclerosis	0.00011	0.000128	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—IL6—atherosclerosis	9.9e-05	0.000114	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—AKT1—atherosclerosis	9.14e-05	0.000106	CbGpPWpGaD
